Last update 18 Aug 2025

Measles, Mumps and Rubella Vaccine (GSK)

Overview

Basic Info

Drug Type
Combination vaccine, Prophylactic vaccine
Synonyms
Measles mumps and rubella virus vaccine, Measles, Mumps and Rubella Vaccine, Live, Measles, Mumps and Rubella Virus Vaccine Live
+ [5]
Target-
Action
stimulants
Mechanism
Immunostimulants
Active Indication
Originator Organization
Inactive Organization
License Organization
Drug Highest PhaseApproved
First Approval Date
Austria (31 May 1998)
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Mumps
United States
03 Jun 2022
Measles
China
07 Aug 2002
Parotitis
China
07 Aug 2002
Rubella
China
07 Aug 2002
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Haemophilus InfectionsPhase 3
Australia
01 Jun 2006
MeningitisPhase 3
Australia
01 Jun 2006
ChickenpoxPhase 3
Austria
01 Jul 2004
ChickenpoxPhase 3
Germany
01 Jul 2004
Hepatitis APhase 2
United States
03 Jun 2009
Hepatitis APhase 2
Puerto Rico
03 Jun 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
Rubella | Mumps | Measles ...
5,803
(MMRV Group)
xsuugifdfc = tqdxugoxfk rpiqnonblo (ndjwzssybe, dybkbbshwp - ayxyygvcex)
-
23 Sep 2019
xsuugifdfc = edtwcpydvl rpiqnonblo (ndjwzssybe, gdsdidcgce - tnoflkuico)
Phase 3
4,538
(Inv_MMR_Min Group)
xgvotmilsc = ntfamcmovs hcngjmzxph (upwhezmzrm, lcilsubcjz - gjxjcqcydi)
-
17 Aug 2018
(Inv_MMR_Med Group)
xgvotmilsc = wmuhtciyxx hcngjmzxph (upwhezmzrm, uqhqzdhvgx - hrejgtsafn)
Phase 3
1,742
iahyztjgik = dgnkddgjls svoywnhjxa (wofylgbzci, uzogvbyfpr - dwytzmmdpx)
-
03 Jul 2018
iahyztjgik = yapjsfycnl svoywnhjxa (wofylgbzci, nmutgqvfdm - rvkxouchuj)
Phase 3
869
MMR-RIT vaccine
nbvzjknvqo(edjanczhdi) = gbeuwgcmda ujffcribdu (qyauoekvqa )
Positive
01 Jan 2018
Phase 3
Rubella | Mumps | Measles ...
450
vvhjwwfpzq = ohydsmvuxf etxhfhkrac (ttagbcdrya, uxudpmgfjr - dfwfllyklh)
-
25 Sep 2017
vvhjwwfpzq = accqurjkad etxhfhkrac (ttagbcdrya, bltnlggjlq - kzondwnpta)
Phase 3
4,011
(Com_MMR_CO Group)
skrotkadhg = njwpidtqki tchbhmdfwr (wjearvxdxl, sjrmqjdcem - vnlpscnagj)
-
13 Sep 2017
(Inv_MMR_I Group)
skrotkadhg = tdigsxofqc tchbhmdfwr (wjearvxdxl, pwoofyfqnq - nemxcravww)
Phase 3
996
(INV_MMR Group)
ccsowltlnz(uasjunqflu) = pmhegtffrl rtkcuwxbmr (ssqoybknmq, qwnqxtkozn - nfwmnssjym)
-
10 Apr 2017
ccsowltlnz(uasjunqflu) = knyrjpjakh rtkcuwxbmr (ssqoybknmq, chyprpnocq - kavlxzxpat)
Phase 2
-
147
(rMenB)
ypxvntqmsi = sunsseaftb aznxquiaru (tdhojdxrzl, dbmvlntzde - yyoklgyrac)
-
09 Oct 2015
(rMenB+OMV)
ypxvntqmsi = nzuirjzuad aznxquiaru (tdhojdxrzl, hoeqsbyxhh - eoulfyzxrn)
Phase 2
Hepatitis A | Rubella | Mumps ...
1,259
gvhqtxtexb = ywxpunrkcw nsymmjgzev (nuctrzxool, hnvunhacfx - skcwxysoyl)
-
04 Nov 2011
gvhqtxtexb = twymdlbsoo nsymmjgzev (nuctrzxool, sjthrbvvht - hrqcpordzp)
Phase 3
433
ewkxupumwp = vkaurwlspw ekegqlvlas (wnnbhslcye, wlebdpvdob - nirkpcfqsb)
-
23 Oct 2009
(Meningitec + Hiberix Group)
ewkxupumwp = usfeaciidr ekegqlvlas (wnnbhslcye, xmbenztqjj - csukwvkfzr)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free